Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2022 Jul 25:10.1097/MPG.0000000000003570. doi: 10.1097/MPG.0000000000003570

Figure 3.

Figure 3.

Bifidobacterium treatment is associated with higher ILA and reduced intestinal inflammation. (A) Fecal ILA concentrations for each probiotic group (B) Fecal calprotectin for each probiotic group (C) Partial spearman correlation between fecal ILA and calprotectin adjusted for gestational age at birth. Boxplots represent medians and interquartile range (IQRCorrelation includes independent samples from infants at 30, 31 and 32 weeks CGA. ** p < 0.01; Wilcoxon rank-sum test with FDR correction for multiple comparisons.